Sita Taibi, PA
Physician Assistant · Medford, ORNPI 1811327281
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 311 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 311 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$915
- AstraZeneca$574
- AbbVie$532
- Novo Nordisk$525
- Lilly USA, LLC$514
- Johnson & Johnson$402
- plus $3K from 29 others
What the payments were for
- Food & beverage$6,121100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 41 | $915 |
| AstraZeneca | 31 | $574 |
| AbbVie | 24 | $532 |
| Novo Nordisk | 30 | $525 |
| Lilly USA, LLC | 28 | $514 |
| Johnson & Johnson | 25 | $402 |
| Amgen | 18 | $387 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $288 |
| Pfizer | 14 | $278 |
| Biohaven Pharmaceuticals, Inc. | 12 | $176 |
| Astellas Pharma US Inc | 7 | $172 |
| Bayer | 6 | $149 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $140 |
| Axsome Therapeutics, Inc. | 5 | $114 |
| Exact Sciences | 4 | $103 |
| Merck | 5 | $93 |
| Amarin Pharma, Inc. | 4 | $87 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $81 |
| Lundbeck LLC | 3 | $70 |
| Sanofi Pasteur Inc. | 3 | $65 |
| Boehringer Ingelheim | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Nestle Healthcare Nutrition Inc. | 2 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $41 |
| Ultragenyx Pharmaceutical Inc. | 2 | $40 |
| Mylan Specialty L.p. | 1 | $39 |
| Dexcom, Inc. | 2 | $32 |
| Aimmune Therapeutics, Inc. | 2 | $30 |
| Hologic Sales And Service, LLC | 1 | $27 |
| Abbott | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $20 |
| Novartis | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Si-bone, Inc. | 1 | $12 |
How this compares
$6,121 in reported general payments places this provider in the 95th percentile of 1,756 physician assistant providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 37 | $54,023 |
| OzempicSemaglutide | 39 | $49,469 |
| EliquisApixaban | 31 | $31,104 |
| XareltoRivaroxaban | 16 | $22,978 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $5,412 |
| Atorvastatin Calcium | 159 | $2,774 |
| Rosuvastatin Calcium | 104 | $1,503 |
| Estradiol | 31 | $1,370 |
| Losartan Potassium | 115 | $1,281 |
| Omeprazole | 77 | $1,138 |
| Bupropion XlBupropion Hcl | 22 | $1,097 |
| Levothyroxine Sodium | 104 | $994 |
| Lisinopril | 150 | $969 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 18 | $832 |
| Amlodipine Besylate | 84 | $787 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $51 | $54,02337 claims |
| Novo NordiskOzempic | $525 | $49,46939 claims |
| PfizerEliquis | $278 | $31,10431 claims |
| Johnson & JohnsonXarelto | $402 | $22,97816 claims |
| GSKAnoro Ellipta | $915 | $5,41212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,756 physician assistant providers in Oregon.
Other physician assistant in Medford
- Debra Allen KutcherMedford$14K
- Christopher DavisMedford$11K
- Ekaterina RollasonMedford$7K
- Mariana CooperMedford$6K
- Devon ParksEugene$62K
- Ryan CainCorvallis$55K
- Sean BrownPortland$43K
- Meegan MangumPortland$25K
- Scott FrazeePortland$24K
- Marissa ReenEugene$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.